SW
ABBV icon

SteelPeak Wealth’s AbbVie ABBV Stock Holding History

SteelPeak Wealth’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.31M Buy
37,009
+372
+1% +$80K 0.24% 86
2026
Q1 		$7.97M Sell
36,637
-4,312
-11% -$957K 0.24% 90
2025
Q4 		$9.36M Buy
40,949
+15,135
+59% +$3.45M 0.3% 72
2025
Q3 		$5.98M Sell
25,814
-23,284
-47% -$4.74M 0.2% 95
2025
Q2 		$9.11M Buy
49,098
+28,338
+137% +$5.27M 0.35% 72
2025
Q1 		$4.35M Buy
20,760
+3,181
+18% +$618K 0.18% 108
2024
Q4 		$3.12M Buy
17,579
+644
+4% +$118K 0.13% 126
2024
Q3 		$3.34M Sell
16,935
-18,529
-52% -$3.46M 0.15% 118
2024
Q2 		$6.08M Buy
35,464
+21,389
+152% +$3.54M 0.28% 76
2024
Q1 		$2.56M Buy
14,075
+1,529
+12% +$264K 0.13% 131
2023
Q4 		$1.94M Sell
12,546
-1,991
-14% -$290K 0.11% 147
2023
Q3 		$2.17M Buy
14,537
+925
+7% +$136K 0.14% 123
2023
Q2 		$1.83M Buy
13,612
+4,741
+53% +$695K 0.11% 130
2023
Q1 		$1.41M Sell
8,871
-1,857
-17% -$284K 0.1% 139
2022
Q4 		$1.73M Sell
10,728
-824
-7% -$126K 0.13% 127
2022
Q3 		$1.55M Sell
11,552
-1,550
-12% -$222K 0.12% 130
2022
Q2 		$2.01M Sell
13,102
-3,146
-19% -$481K 0.14% 114
2022
Q1 		$2.63M Sell
16,248
-196
-1% -$28.5K 0.15% 106
2021
Q4 		$2.23M Sell
16,444
-9,743
-37% -$1.15M 0.13% 114
2021
Q3 		$2.83M Sell
26,187
-7,175
-22% -$820K 0.19% 91
2021
Q2 		$3.76M Buy
33,362
+13,744
+70% +$1.55M 0.26% 82
2021
Q1 		$2.12M Buy
19,618
+8,660
+79% +$926K 0.17% 102
2020
Q4 		$1.17M Buy
10,958
+902
+9% +$86.7K 0.11% 141
2020
Q3 		$881K Buy
10,056
+4,126
+70% +$388K 0.09% 149
2020
Q2 		$582K Sell
5,930
-9,076
-60% -$799K 0.07% 156
2020
Q1 		$1.14M Sell
15,006
-1,162
-7% -$99K 0.18% 101
2019
Q4 		$1.43M Buy
+16,168
New +$1.34M 0.2% 98

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

SteelPeak Wealth's ABBV Position: Q2 2026 in Review

SteelPeak Wealth increased its AbbVie (ABBV) stake by 1% in Q2 2026, buying an estimated $80K and bringing the position to 37,009 shares worth $9.31M. The position accounts for 0.24% of the portfolio, ranked #86.

SteelPeak Wealth first reported a position in ABBV in Q4 2019 and has held it in 27 quarters since. The position peaked at $9.36M in Q4 2025. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • SteelPeak Wealth held 37,009 shares of AbbVie worth $9.31M as of Q2 2026.
  • SteelPeak Wealth bought 372 AbbVie shares in Q2 2026, an estimated $80K.
  • AbbVie made up 0.24% of SteelPeak Wealth's portfolio in Q2 2026, its #86 holding.
  • SteelPeak Wealth first reported a position in AbbVie in Q4 2019 and has held it in 27 quarters since.
  • SteelPeak Wealth's AbbVie position peaked at $9.36M in Q4 2025.
  • 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on SteelPeak Wealth's 13F filing for Q2 2026, filed 13 Jul 2026.